Literature DB >> 9648789

Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature.

G W Boland1, M J Lee, G S Gazelle, E F Halpern, M M McNicholas, P R Mueller.   

Abstract

OBJECTIVE: Unenhanced CT scanning can reliably characterize incidentally detected adrenal masses when observers use density measurements of the adrenal gland. However, controversy exists as to the optimal density threshold required to differentiate benign from malignant lesions. This study attempts to establish a consensus by performing a pooled analysis of data found in the CT literature.
MATERIALS AND METHODS: Ten CT reports were analyzed, from which individual adrenal lesion density measurements were obtained for 495 adrenal lesions (272 benign lesions and 223 malignant lesions). Threshold analysis generated a range of sensitivities and specificities for lesion characterization at different density thresholds.
RESULTS: Sensitivity for characterizing a lesion as benign ranged from 47% at a threshold of 2 H to 88% at a threshold of 20 H. Similarly, specificity varied from 100% at a threshold of 2 H to 84% at a threshold of 20 H.
CONCLUSION: The attempt to be absolutely certain that an adrenal lesion is benign may lead to an unacceptably low sensitivity for lesion characterization. The threshold chosen will depend on the patient population and the cost-benefit approach to patient care.

Entities:  

Mesh:

Year:  1998        PMID: 9648789     DOI: 10.2214/ajr.171.1.9648789

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  98 in total

Review 1.  FDG PET in the management of patients with adrenal masses and adrenocortical carcinoma.

Authors:  Désirée Deandreis; Sophie Leboulleux; Caroline Caramella; Martin Schlumberger; Eric Baudin
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

2.  Determinants for malignancy in surgically treated adrenal lesions.

Authors:  Lucie Wright; Erik Nordenström; Martin Almquist
Journal:  Langenbecks Arch Surg       Date:  2011-09-21       Impact factor: 3.445

Review 3.  Conventional imaging in adrenocortical carcinoma: update and perspectives.

Authors:  William F Young
Journal:  Horm Cancer       Date:  2011-12       Impact factor: 3.869

4.  Surgical approach in adrenal incidentalomas: Report of thirteen cases and review of the literature.

Authors:  Hasan Erdem; Süleyman Çetinkünar; Faruk Kuyucu; Hakan Erçil; Mustafa Görür; Selim Sözen
Journal:  Ulus Cerrahi Derg       Date:  2015-08-18

5.  Utility of the 10 Hounsfield unit threshold for identifying adrenal adenomas: Can we improve?

Authors:  Michael J Kirsch; Miranda W Kohli; Kristin L Long; Susan C Pitt; David F Schneider; Rebecca S Sippel; Priya H Dedhia
Journal:  Am J Surg       Date:  2020-04-21       Impact factor: 2.565

Review 6.  Contemporary adrenal scintigraphy.

Authors:  Milton D Gross; Anca Avram; Lorraine M Fig; Domenico Rubello
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-11-25       Impact factor: 9.236

7.  [Adrenal tumors: principles of imaging and differential diagnostics].

Authors:  C Degenhart
Journal:  Radiologe       Date:  2014-10       Impact factor: 0.635

8.  Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours?

Authors:  L Tessonnier; F Sebag; F F Palazzo; C Colavolpe; C De Micco; J Mancini; B Conte-Devolx; J F Henry; O Mundler; D Taïeb
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-06-20       Impact factor: 9.236

9.  Can single-phase dual-energy CT reliably identify adrenal adenomas?

Authors:  A Helck; N Hummel; F G Meinel; T Johnson; K Nikolaou; A Graser
Journal:  Eur Radiol       Date:  2014-05-08       Impact factor: 5.315

10.  Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.

Authors:  Sung Hee Park; Myeong-Jin Kim; Joo Hee Kim; Joon Seok Lim; Ki Whang Kim
Journal:  Korean J Radiol       Date:  2007 Jul-Aug       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.